Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. PURE Bioscience, Inc.
  6. News
  7. Summary
    PURE   US74621T2096

PURE BIOSCIENCE, INC.

(PURE)
Delayed Quote. Delayed OTC Markets - 10/21 01:19:00 pm
0.375 USD   -3.72%
08/23PURE BIOSCIENCE, INC. : Other Events (form 8-K)
AQ
08/23Pure Bioscience, Inc. Appoints Ivan Chen as Chair of the Board
CI
06/17NORTH AMERICAN MORNING BRIEFING : Markets Slip and -3-
DJ
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Pure Bioscience, Inc. Reports Earnings Results for the Third Quarter Ended April 30, 2021

06/15/2021 | 04:11pm EDT

PURE Bioscience, Inc. announced earnings results for the third quarter ended April 30, 2021. For the third quarter, the company announced total revenue was USD 561,000 compared to USD 2.221 million a year ago. Operating loss was USD 810,000 compared to operating Income of USD 474,000 a year ago. Net loss was USD 811,000 compared to net income of USD 473,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.01 a year ago. For the nine months, total revenue was USD 3.068 million compared to USD 2.968 million a year ago. Operating loss was USD 1.583 million compared to USD 1.319 million a year ago. Net loss was USD 1.586 million compared to USD 1.318 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.


© S&P Capital IQ 2021
All news about PURE BIOSCIENCE, INC.
08/23PURE BIOSCIENCE, INC. : Other Events (form 8-K)
AQ
08/23Pure Bioscience, Inc. Appoints Ivan Chen as Chair of the Board
CI
06/17NORTH AMERICAN MORNING BRIEFING : Markets Slip and -3-
DJ
06/15PURE BIOSCIENCE : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
06/15Pure Bioscience, Inc. Reports Earnings Results for the Third Quarter Ended April 30, 20..
CI
06/15PURE BIOSCIENCE, INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
06/15PURE BIOSCIENCE : Reports Fiscal 2021 Third Quarter and Nine-Month Financial Results
BU
05/19PURE BIOSCIENCE : Certificate of Amendment of Certificate of Incorporation of PURE Bioscie..
PU
05/19PURE BIOSCIENCE, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F..
AQ
03/15PURE BIOSCIENCE : Management's Discussion and Analysis of Financial Condition and Results ..
AQ
More news
Financials (USD)
Sales 2020 6,92 M - -
Net income 2020 0,00 M - -
Net cash 2020 3,84 M - -
P/E ratio 2020 30 426x
Yield 2020 -
Capitalization 32,7 M 32,7 M -
EV / Sales 2019 12,7x
EV / Sales 2020 17,4x
Nbr of Employees -
Free-Float 65,7%
Chart PURE BIOSCIENCE, INC.
Duration : Period :
PURE Bioscience, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Tom Y. Lee Chairman, President & Chief Executive Officer
Mark S. Elliott VP, Chief Financial & Accounting Officer
Dolana Blount VP-Technology Development & Regulatory Affairs
Tom Myers Chief Operating Officer & Director
Ivan Chen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PURE BIOSCIENCE, INC.-50.19%33
CHURCH & DWIGHT CO., INC.-4.16%20 527
THE CLOROX COMPANY-20.73%19 778
PT UNILEVER INDONESIA TBK-31.97%13 851
LION CORPORATION-23.94%4 856
WD-40 COMPANY-20.62%2 868